Molly 2.25 modular platform autoinjector

Products

Information

Molly 2.25 is a large-volume variant of the Molly autoinjector, developed to support the delivery of larger-volume biologics with the same 2-step operation. Built on a modular platform, Molly 2.25 enables high-volume manufacturing, faster development, and flexible design for unique branding needs. Molly 2.25 can be configured with a pre-filled syringe (PFS) featuring an 8 mm or ½ inch needle, offering flexibility to support diverse drug delivery requirements.

Product Categories

Finished Dosage Forms
- Injectables
Packaging Materials and Equipment
- Injectable systems and components
  - Auto-injector
  - Cost-effective injector
- Medical Devices and Medical Packaging
Drug Delivery Devices & Systems
- High viscosity drug delivery device

Distribution Areas

North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesSouth America (e.g. Brazil, Colombia)

SHL MedicalSHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients' independence.

Molly 2.25 modular platform autoinjector

Information

Log in